Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

UNBELIEVABLE: 2 - The Untold Story

AI Creates 16 Brand-New Viral Genomes Never Seen in Nature, Scientists Call It a Turning Point

A Science study shows generative AI can move beyond analysing DNA to designing complete viral genomes, raising new questions about biological design and biosecurity.

International Business Times UK

First AI to Design Brand New Viruses Leads Scientists to Warn of 'Urgent Biosafety' Concerns

Researchers have used AI to design complete viral genomes that function in labs, potentially advancing medical research but raising biosafety concerns. The breakthrough could aid in combating antibiotic-resistant infections.

International Business Times UK

AI creates 16 new viruses that never existed in nature after learning DNA’s pattern from 9 trillion nucleotides — experts warn such applications are way ahead of necessary guardrails

Researchers used Evo AI models trained on trillions of DNA building blocks to design entirely new viral genomes, 16 of which became viable bacteriophages capable of infecting and reproducing inside E. coli.

Tom’s Hardware

From analysis to the latest developments in health,
read the most diverse news in one place.

Army Refers 272 Specifications Against Fort Hood Physician Involving 93 Alleged Victims

The Army referred nine charges and 272 specifications against a Fort Hood OB-GYN involving 93 alleged victims. The allegations are unproven.

Medical Daily

Datadog’s Drop Says More About Expectations Than Earnings

Datadog shares fell 19% despite beating revenue and earnings estimates and raising guidance, as high prior expectations and one large client's usage cutback overshadowed otherwise broad-based growth.

MarketBeat

AI experts are panicking about a terrifying new era of hacking. Here’s what you can do

A run of attacks by ‘rogue’ artificial intelligence systems as well as powerful new cyber security tools have brought new worry about the safety and security of our technology

The Independent UK

Elon Musk Is Asking Investors to Trust Him Again as SpaceX Focuses on More Than Just Space

SpaceX delivered a strong Q2 earnings report, but massive AI spending became the story investors couldn’t ignore.

Barchart

Read news from The Economist, FT, and more,
with one subscription

Kevin O'Leary Sat Out SpaceX's IPO— Now He's Plotting His Entry as Elon Musk's Empire Takes Shape: 'As the Stock Settles... I'll Be Watching Closely...'

Investor and television personality Kevin O’Leary said he may begin buying SpaceX (NASDAQ:SPCX) shares once post-IPO volatility settles, arguing that the bigger long-term opportunity lies in Elon Musk potentially connecting SpaceX with Tesla Inc. (NASDAQ:TSLA), artificial intelligence, robotics and autonomous driving.

Benzinga

FDA Approves First Narcolepsy Drug That Targets the Brain Signal Loss Behind the Disorder

FDA-approved Orzeyful, the first narcolepsy type 1 drug that restores orexin signaling instead of treating symptoms one at a time.

Medical Daily

Meta’s AI hacked another company and now the industry’s ‘under control’ narrative takes another hit

A pattern that's getting harder to ignore.

We Got This Covered

Oil extends gains and stocks mostly down on fresh Hormuz worries

HONG KONG - Oil prices extended gains and most stocks fell further on Friday amid fading optimism over a deal to reopen the Strait of Hormuz, as reports said Iran was planning to block US and Israeli ships from the waterway as part of a deal with Oman.

Bangkok Post

AI Created Fake Identities To Approve Malicious Code, New Report Shows, As Evidence Of Unpredictable AI Mounts

AI agents created fake identities and attempted to trick real people into approving malicious code in an attempted supply-chain attack on real open-source software.

International Business Times

Arizona Is Paying $5 Million for an Ibogaine Trial in Brain Injury, Using a Drug That Is Illegal Federally and Can Stop the Heart

Arizona granted Barrow Neurological Institute $5 million for an ibogaine trial in traumatic brain injury. The design, the Schedule I status, and the cardiac risk.

Medical Daily

Business Brief (Aug. 6): China Announces Trade Countermeasures Against the U.S.

Moonshot AI seeks $50 billion valuation in new funding round, Chinese mainland tax authorities begin levying returns from offshore insurance policies

Caixin Global

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Alphabet Stock Dives as Key AI Leadership Exits

Alphabet Inc (NASDAQ:GOOG) shares are dropping Wednesday after the company’s longtime chief scientist announced he is leaving to launch an AI startup. Here’s what you need to know.

The Guardian - UK

Cost of filling up a tank of diesel reaches £100, as oil prices rise back above $80 a barrel again – as it happened

UK economy strengthens as service sector returns to growth and car sales jump

The Economic Times

OpenAI’s Astra solves 10 longstanding math problems, igniting new debate

Apart from praise, the news, published on August 1, also kickstarted a debate on social media over whether the achievement is Fields medal-worthy — and what these honours mean in the artificial intelligence (AI) era. The Fields medal is awarded by the International Mathematical Union (IMU), and is often called…

The Economic Times

Experimental AI systems have been going on hacking sprees

The incidents show testing advanced AI models is no longer a controlled exercise. And the companies behind them need to do more to keep AI's most dangerous capabilities safely contained.

Get all your
news in one place.

100's of premium titles.
One news app.

Fortune

SpaceX revenue surges 92% to $7.8 billion, blowing past Wall Street expectations by nearly $1 billion

SpaceX posted $7.8 billion in quarterly revenue, surging ahead of the $6.9 billion consensus, as Starlink subscribers doubled to 12 million and $14.1 billion in new AI contracts turbocharged financial results.

Barchart

JPMorgan Chase CEO Jamie Dimon Says AI 'Will Cure Cancers' — But How Should You Invest?

The typically bearish Dimon recently offered some wildly optimistic comments on the potential for artificial intelligence to solve one of the biggest healthcare quandaries in modern medicine.

The Economic Times

A day after stunning BJP in Bankipur, JSP founder Prashant Kishor continues to gun for Bihar CM Samrat Choudhary

Prashant Kishor criticized Bihar Chief Minister Samrat Choudhary, linking him to past RJD rule. Kishor claimed people see Choudhary as an attempt to revive 'jungle raj' in Bihar. He celebrated his party's victory in the Bankipur by-poll, which was a BJP stronghold. Kishor stated that no party can claim a…

Barchart

Palantir CEO Alex Karp Says Frontier AI Labs Will Steal Your IP, Your Know-How, and Your Expertise — ‘You Deserve To Be Colonized’

During the PLTR Q2 conference call with analysts, CEO Alex Karp served up some fiery rhetoric about the moral and ethical issues he has with frontier AI labs.

The Conversation

Experimental AI systems have been going on hacking sprees

In the past ten days, two of the companies leading the artificial intelligence (AI) boom discovered their own powerful, semi-autonomous models had hacked into real-world systems during testing in four distinct incidents.

The Times of India

Man rejects Rs 2 crore offer in India and chooses $160K in the US because...

A LinkedIn post comparing the salaries between India and the US triggered much debate as a man rejected Rs 2 crore offer in India and chose $160K in the US. A Dubai-based AI leader, CJ Teja Sai, shared the story of the US-based friend who made this decision to choose…

Barchart

1 Japanese Company Just Waved a Red Flag for Micron Stock. How to Play It Here.

Kioxia’s weak outlook has cast fresh doubt on the AI memory boom. Here’s how investors should approach Micron stock.

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Google

31,938 stories

Bharatiya Janata Party